DNA
Price:
$9.17
Market Cap:
$599.03M
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Sele...[Read more]
Industry
Biotechnology
IPO Date
2021-04-19
Stock Exchange
NYSE
Ticker
DNA
According to Ginkgo Bioworks Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -57.31%. This represents a change of 290.02% compared to the average of -14.69% of the last 4 quarters.
The mean historical ROE of Ginkgo Bioworks Holdings, Inc. over the last ten years is -73.39%. The current -57.31% ROE has changed -21.91% with respect to the historical average. Over the past ten years (40 quarters), DNA's ROE was at its highest in in the June 2020 quarter at 0%. The ROE was at its lowest in in the December 2021 quarter at -106.33%.
Average
-73.39%
Median
-76.39%
Minimum
-121.57%
Maximum
-24.20%
Discovering the peaks and valleys of Ginkgo Bioworks Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 343.01%
Maximum Annual ROE = -24.20%
Minimum Annual Increase = -32.87%
Minimum Annual ROE = -121.57%
| Year | ROE | Change |
|---|---|---|
| 2025 | -61.50% | -19.50% |
| 2024 | -76.39% | -6.13% |
| 2023 | -81.38% | -32.87% |
| 2022 | -121.23% | -0.28% |
| 2021 | -121.57% | 343.01% |
| 2020 | -27.44% | 13.39% |
The current ROE of Ginkgo Bioworks Holdings, Inc. (DNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-73.09%
5-year avg
-92.41%
10-year avg
-73.39%
Ginkgo Bioworks Holdings, Inc.’s ROE is greater than Iovance Biotherapeutics, Inc. (-50.17%), greater than Replimune Group, Inc. (-102.69%), greater than MBX Biosciences, Inc. Common Stock (-24.50%), less than MeiraGTx Holdings plc (474.91%), greater than ArriVent BioPharma, Inc. Common Stock (-48.98%), greater than Maravai LifeSciences Holdings, Inc. (-44.72%), greater than Astria Therapeutics, Inc. (-45.01%), greater than Vir Biotechnology, Inc. (-53.31%), greater than Arvinas, Inc. (-44.39%), greater than Valneva SE (-106.22%),
| Company | ROE | Market cap |
|---|---|---|
| -50.17% | $1.40B | |
| -102.69% | $841.41M | |
| -24.50% | $1.45B | |
| 474.91% | $1.05B | |
| -48.98% | $1.48B | |
| -44.72% | $1.44B | |
| -45.01% | $718.13M | |
| -53.31% | $1.54B | |
| -44.39% | $494.88M | |
| -106.22% | $510.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ginkgo Bioworks Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ginkgo Bioworks Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ginkgo Bioworks Holdings, Inc.'s ROE?
How is the ROE calculated for Ginkgo Bioworks Holdings, Inc. (DNA)?
What is the highest ROE for Ginkgo Bioworks Holdings, Inc. (DNA)?
What is the 3-year average ROE for Ginkgo Bioworks Holdings, Inc. (DNA)?
What is the 5-year average ROE for Ginkgo Bioworks Holdings, Inc. (DNA)?
How does the current ROE for Ginkgo Bioworks Holdings, Inc. (DNA) compare to its historical average?